Page 58 - IMO-1-1

Innovative Medicines & Omics Antioxidant nanomedicines for therapies

doi: 10.1021/acsnano.2c03422 doi: 10.3390/ijms24010340
112. Ouriel K. Peripheral arterial disease. Lancet. 124. Mandinov L, Mandinova A, Kyurkchiev S, et al. Copper
2001;358(9289):1257-1264. chelation represses the vascular response to injury. Proc
Natl Acad Sci U S A. 2003;100(11):6700-6705.
doi: 10.1016/S0140-6736(01)06351-6
doi: 10.1073/pnas.1231994100
113. Criqui MH, Aboyans V. Epidemiology of peripheral artery
disease. Circ Res. 2015;116(9):1509-1526. 125. Isselbacher EM. Thoracic and abdominal aortic aneurysms.
Circulation. 2005;111(6):816-828.
doi: 10.1161/CIRCRESAHA.116.303849
doi: 10.1161/01.CIR.0000154569.08857.7A
114. Koutakis P, Ismaeel A, Farmer P, et al. Oxidative stress and
antioxidant treatment in patients with peripheral artery 126. Kent KC. Clinical practice. Abdominal aortic aneurysms.
disease. Physiol Rep. 2018;6(7):e13650. N Engl J Med. 2014;371(22):2101-2108.
doi: 10.14814/phy2.13650 doi: 10.1056/NEJMcp1401430
115. Brevetti G, Giugliano G, Brevetti L, Hiatt WR. Inflammation in 127. Schanzer A, Oderich GS. Management of abdominal aortic
peripheral artery disease. Circulation. 2010;122(18):1862-1875. aneurysms. N Engl J Med. 2021;385(18):1690-1698.
doi: 10.1161/CIRCULATIONAHA.109.918417 doi: 10.1056/NEJMcp2108504
116. Violi F, Loffredo L, Mancini A, Marcoccia A. Antioxidants in 128. Chaikof EL, Dalman RL, Eskandari MK, et al. The society
peripheral arterial disease. Curr Drug Targets. 2003;4(8):651-655. for vascular surgery practice guidelines on the care of
patients with an abdominal aortic aneurysm. J Vasc Surg.
doi: 10.2174/1389450033490786 2018;67(1):2-77.e2.
117. Giannopoulos G, Angelidis C, Vogiatzi G, Cleman MW, doi: 10.1016/j.jvs.2017.10.044
Deftereos S. Antioxidant treatment in peripheral artery
disease: The rationale is there, but what about clinical 129. McCormick ML, Gavrila D, Weintraub NL. Role of oxidative
results? Curr Opin Pharmacol. 2018;39:53-59. stress in the pathogenesis of abdominal aortic aneurysms.
Arterioscler Thromb Vasc Biol. 2007;27(3):461-469.
doi: 10.1016/j.coph.2018.01.008
doi: 10.1161/01.ATV.0000257552.94483.14
118. Jung E, Lee J, Jeong L, et al. Stimulus-activatable echogenic 130. Miller FJ Jr., Sharp WJ, Fang X, Oberley LW, Oberley TD,
maltodextrin nanoparticles as nanotheranostic agents for Weintraub NL. Oxidative stress in human abdominal aortic
peripheral arterial disease. Biomaterials. 2019;192:282-291.
aneurysms: A potential mediator of aneurysmal remodeling.
doi: 10.1016/j.biomaterials.2018.11.022 Arterioscler Thromb Vasc Biol. 2002;22(4):560-565.

119. Guo J, Ping Y, Ejima H, et al. Engineering multifunctional doi: 10.1161/01.atv.0000013778.72404.30
capsules through the assembly of metal-phenolic networks. 131. Shimizu K, Mitchell RN, Libby P. Inflammation and
Angew Chem Int Ed Engl. 2014;53(22):5546-5551. cellular immune responses in abdominal aortic aneurysms.
doi: 10.1002/anie.201311136 Arterioscler Thromb Vasc Biol. 2006;26(5):987-994.
120. Rahim MA, Kristufek SL, Pan S, Richardson JJ, Caruso F. doi: 10.1161/01.ATV.0000214999.12921.4f
Phenolic building blocks for the assembly of functional 132. Gao J, Cao H, Hu G, et al. The mechanism and therapy
materials. Angew Chem Int Ed Engl. 2019;58(7):1904-1927. of aortic aneurysms. Signal Transduct Target Ther.
doi: 10.1002/anie.201807804 2023;8(1):55.
121. Zhou J, Lin Z, Ju Y, Rahim MA, Richardson JJ, Caruso F. doi: 10.1038/s41392-023-01325-7
Polyphenol-mediated assembly for particle engineering. 133. Lin W, Hu K, Li C, et al. A multi-bioactive nanomicelle-
Acc Chem Res. 2020;53(7):1269-1278. based “one stone for multiple birds” strategy for precision
doi: 10.1021/acs.accounts.0c00150 therapy of abdominal aortic aneurysms. Adv Mater.
2022;34(44):e2204455.
122. Duan J, Chen Z, Liang X, et al. Construction and
application of therapeutic metal-polyphenol capsule for doi: 10.1002/adma.202204455
peripheral artery disease. Biomaterials. 2020;255:120199. 134. Wilcox CS, Pearlman A. Chemistry and antihypertensive
doi: 10.1016/j.biomaterials.2020.120199 effects of tempol and other nitroxides. Pharmacol Rev.
2008;60(4):418-469.
123. Mokra D, Joskova M, Mokry J. Therapeutic effects of green
tea polyphenol (‒)-epigallocatechin-3-gallate (EGCG) in doi: 10.1124/pr.108.000240
relation to molecular pathways controlling inflammation, 135. LeMaire SA, Russell L. Epidemiology of thoracic aortic
oxidative stress, and apoptosis. Int J Mol Sci. 2022;24(1):340. dissection. Nat Rev Cardiol. 2011;8(2):103-113.

Volume 1 Issue 1 (2024) 52 doi: 10.36922/imo.2527